Millipore Sigma Vibrant Logo

504596 TCN-201 - CAS 852918-02-6 - Calbiochem

TCN-201 - CAS 852918-02-6 - Calbiochem: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: NMDA Antagonist X, 3-Chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide

Primary Target: NMDA receptors
View Products on Sigmaaldrich.com
504596
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Tabla espec. clave

      CAS #Empirical Formula
      852918-02-6C₂₁H₁₇ClFN₃O₄S
      Description
      Overview

      This product has been discontinued.



      A negative allosteric modulator selective for NR2A containing NMDA receptors (pIC50 = 6.8 and <4.3 µM for NR2A and NR2B, respectively). No effect on NR2B-containing NMDA receptors with concentrations less than 50 mM. Inhibition on NR2A containing NMDA receptors is glycine (or D-serine)-binding, but not glutamate-binding, dependent.
      Catalogue Number504596
      Brand Family Calbiochem®
      SynonymsNMDA Antagonist X, 3-Chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide
      References
      ReferencesBettini. E., et al. 2010. J. Pharm. Exp. Ther. 335, 644.
      Shin, A., et al. 2011. Br. J. Pharmacol. 166, 1002.
      Edman, S., et al. 2012. Neuropharmacology 63, 441.
      Hansen, K., et al. 2012. J. Neurosci. 32, 6197.
      Product Information
      CAS number852918-02-6
      FormWhite powder
      Hill FormulaC₂₁H₁₇ClFN₃O₄S
      Chemical formulaC₂₁H₁₇ClFN₃O₄S
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetNMDA receptors
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      504596 0

      Documentation

      TCN-201 - CAS 852918-02-6 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Referencias bibliográficas

      Visión general referencias
      Bettini. E., et al. 2010. J. Pharm. Exp. Ther. 335, 644.
      Shin, A., et al. 2011. Br. J. Pharmacol. 166, 1002.
      Edman, S., et al. 2012. Neuropharmacology 63, 441.
      Hansen, K., et al. 2012. J. Neurosci. 32, 6197.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-June-2013 JSW
      SynonymsNMDA Antagonist X, 3-Chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide
      DescriptionA negative allosteric modulator selective for NR2A containing NMDA receptors (pIC50 = 6.8 and <4.3 µM for NR2A and NR2B, respectively). No effect on NR2B-containing NMDA receptors with concentrations less than 50 mM. Inhibition on NR2A containing NMDA receptors is glycine (or D-serine)-binding, but not glutamate-binding, dependent.
      FormWhite powder
      CAS number852918-02-6
      Chemical formulaC₂₁H₁₇ClFN₃O₄S
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBettini. E., et al. 2010. J. Pharm. Exp. Ther. 335, 644.
      Shin, A., et al. 2011. Br. J. Pharmacol. 166, 1002.
      Edman, S., et al. 2012. Neuropharmacology 63, 441.
      Hansen, K., et al. 2012. J. Neurosci. 32, 6197.